Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events (CHANCE)

This study has been completed.
Sponsor:
Collaborator:
University of California, San Francisco
Information provided by (Responsible Party):
yongjun wang, Ministry of Science and Technology of the People´s Republic of China
ClinicalTrials.gov Identifier:
NCT00979589
First received: September 17, 2009
Last updated: March 11, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):